Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
February 2012
Features
Editorial
When One Size Doesn’t Fit All
CPOE systems should be smarter. Local customization of individual medication-related alerts is a good place to start.
Karl A. Matuszewski, MS, PharmD
Commentary
The FDA’s Social Media Guidelines Are Here … Were They Worth the Wait?
The FDA has delivered its highly anticipated guidelines for industry on how to
respond to unsolicited requests (via social media platforms) for off-label information about prescription drugs and medical devices. The reviews have been mixed.
Miriam Reisman
Cost Analysis Before and After Implementation of a Computerized Physician Order Entry Order Form for Enoxaparin
The authors set out to determine whether a computerized physician order entry (CPOE) order form for enoxaparin would result in a lower cost of drug therapy per day if patients were switched to once-daily administration. Use of the CPOE enoxaparin order form did not reduce the daily cost of therapy, although cost savings did result when the hospital’s protocol was followed.
Rebecca S. Pettit, PharmD, MBA, BCPS; Christopher R. Zimmerman, PharmD,
BCPS; Cesar Alaniz, PharmD; and Michael P. Dorsch, PharmD, MS, BCPS
Meeting Highlights
34th Annual San Antonio Breast Cancer Symposium and 53rd American Society of Hematology Annual Meeting and Exposition
Walter Alexander
Departments
Prescription: Washington
Under Scrutiny: FDA’s REMS for Opioids
Acceptance or Rejection by Stakeholders Will Influence Congress
Some say that the FDA’s proposed REMS opioids initiative does not go far enough to protect patients.
Stephen Barlas
Medication Errors
Misprogramming Patient-Controlled Analgesia Levels Causes Dosing Errors
Misprogramming pump levels of patient-controlled analgesia can lead to dosing errors.
Matthew Grissinger, RPh, FASCP
New Drugs/Drug News/New Medical Devices
FDA approvals, drug indications, and updates
Pharmaceutical Approval Update
Advate to prevent bleeding; Edarbi and Edarbyclor for hypertension; and Anturol gel for overactive bladder
Marvin M. Goldenberg, PhD, RPh, MS
Drug Forecast
Indacaterol (Arcapta Neohaler) for Chronic Obstructive Pulmonary Disease
Arcapta Neohaler for chronic obstructive pulmonary disease
Rachel M. Slaton, PharmD, BCPS; and Danielle L. Cruthirds, PhD
